Samsung Launches New AI-Enabled OB/GYN Ultrasound System
The HERA W10 Elite ultrasound platform provides enhanced visualization features and artificial intelligence (AI)-aided measurement capabilities.
Could the HERA W10 Elite reinvent ultrasound imaging in obstetrics and gynecology care?
The newly launched ultrasound system offers 2D and 3D visualization of microcirculatory and slow blood with the Advanced MV-Flow™ feature and a large organic light-emitting diode (OLED) display that provides improved characterization of diverse ultrasound images, according to Samsung, the manufacturer of the HERA W10 Elite system.
Samsung said the HERA W10 Elite also has HeartAssist™, an artificial intelligence (AI)-enhanced feature that provides automated measurement views to facilitate diagnosis of the fetal heart.
(Editor’s note: For related content, see “Adjunctive AI Software for Cardiac Ultrasound Gets FDA Nod” and “Emerging Trends in AI, Ultrasound and OB/GYN Care.”)
Other planned features, pending 510(k) clearance from the Food and Drug Administration (FDA), include a new EV2-12 transducer that allows imaging of the fetal heart and brain starting at eight weeks and Biometry Assist™, which allows one-click measurement of fetal growth parameters.
“Women’s health is a fast-growing field that requires state-of-the-art equipment for patient care. The HERA W10 Elite will bring visionary change to obstetrics and gynecology with sophisticated image processing and an ergonomic-friendly design,” noted Tracy Bury, Women’s Health Ultrasound Business Leader with Boston Imaging, the United States headquarters for Samsung’s digital radiography and ultrasound business.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
